Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
Medicus Pharma provides update on SKNJCT-003 phase 2 study to treat nodular basal cell carcinoma: Philadelphia Monday, February 17, 2025, 18:00 Hrs [IST] Medicus Pharma Ltd., a bi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback